The SonR system comprises the SonR hemodynamic sensor which is embedded in the SonRtip atrial pacing lead and the Paradym RF SonR CRT-D device.
SonR automatically optimizes every week to adapt to the patient’s changing condition and provides patient’s real life activities and these measurements are transmitted to the CRT-D device which uses them to determine the best settings for the patient.
SonR measurements correspond to LVdP/dtmax, the standard for assessing left ventricular (LV) contractility, an indicator of cardiac performance.
University Hospital Philippe Ritter said providing weekly optimization both at rest and exercise is a significant step forward in the treatment of heart failure patients.
Sorin Group CRM Business Unit president Stefano Di Lullo said the introduction of this new CRT-D system provides new horizons in heart failure treatment options and is a reflection of their commitment to innovation in the hemodynamic management of heart failure patients.
